increasing in production capacity. 3. Selling expenses For the year end of 2019, the selling expenses was 13.28 million baht or 3.27% from sale revenue compare to 11.38 million baht with is higher in the same
operating revenue breakdown by business segment. IV Expense (Unit: Million Baht) 2019 2018 Change Change (%) Selling expenses 584 825 (241) (29) Administrative expenses 1,671 2,071 (400) (19) Finance cost 390
%) Selling & Administrative Expenses 253.64 223.16 30.48 13.66% Finance Cost 61.61 83.03 (21.42) (25.80%) EBT 175.02 158.75 16.26 10.25% Tax (21.45) (22.25) (0.08) (3.58%) Total Comprehensive Income 153.57
million baht, decreased 0.9 million baht or 25.0 percent compared with Q2/2016. (4) Selling and Administrative Expenses For Q2/2017, the company had selling and administrative expenses of 28.0 million baht
17.60 1.88% 28.28 5.26% -10.68 -37.78% Total Income 936.78 100.00% 537.52 100.00% 399.26 74.28% Expense Cost of sales 746.55 79.69% 326.94 60.82% 419.61 128.34% Selling expenses 51.52 5.50% 57.61 10.72
sales in third quarter 2017 decreased. (3) Ethanol Business, in third quarter 2017, compared to the same period of previous year, the company had increased in performance from the increase in selling
personnel to support its expansion such as Cardiac Medicine department and Opthalmology department. Selling Expenses For the 6-month periods of 2015 and 2016 , the Company and its subsidiary incurred selling
and amortization expenses. The proportion of the costs of hospital operations incurred compared to the total revenues for the year 2015 and 2016 were 30.6%, 24.4%, 23.5% and 10.2% respectively. Selling
cost of good was 59.5 percent. (3) Other Income For Q3/2017, the company had other income of 4.3 million baht, increased 1.5 million baht or 56.1 percent compared with Q3/2016. (4) Selling and